ReShape Lifesciences Inc (RSLS) — Net Asset Quality Index
ReShape Lifesciences Inc (RSLS) has a Net Asset Quality Index of 64.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $9.03 Million minus total liabilities of $3.20 Million yields net assets of $5.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read ReShape Lifesciences Inc total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
ReShape Lifesciences Inc Net Asset Quality Index Over Time (2003–2024)
This chart shows how ReShape Lifesciences Inc's Net Asset Quality Index has evolved across 21 annual periods from 2003 to 2024. As of June 2025, the index stands at 64.6%, representing net assets of $5.83 Million against total assets of $9.03 Million USD. For live market cap and overall valuation, see ReShape Lifesciences Inc market cap and net worth.
Annual Net Asset Quality Index for ReShape Lifesciences Inc (2003–2024)
The table below presents the year-by-year Net Asset Quality Index for ReShape Lifesciences Inc from 2003 to 2024, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check ReShape Lifesciences Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -5.3% | $-253.00K | $4.79 Million | $5.05 Million | ▼ -67.8 pp |
| 2023 | 62.5% | $6.66 Million | $10.66 Million | $4.00 Million | ▲ +29.6 pp |
| 2022 | 32.9% | $3.66 Million | $11.14 Million | $7.48 Million | ▼ -52.1 pp |
| 2021 | 84.9% | $46.07 Million | $54.26 Million | $8.19 Million | ▲ +45.8 pp |
| 2020 | 39.1% | $14.49 Million | $37.06 Million | $22.57 Million | ▼ -21.7 pp |
| 2019 | 60.8% | $24.11 Million | $39.66 Million | $15.55 Million | ▼ -7.6 pp |
| 2018 | 68.4% | $31.66 Million | $46.27 Million | $14.61 Million | ▼ -17.7 pp |
| 2017 | 86.1% | $76.37 Million | $88.70 Million | $12.34 Million | ▲ +44.3 pp |
| 2016 | 41.7% | $2.94 Million | $7.04 Million | $4.10 Million | ▲ +10.0 pp |
| 2015 | 31.7% | $3.67 Million | $11.59 Million | $7.91 Million | ▼ -14.6 pp |
| 2014 | 46.3% | $6.66 Million | $14.39 Million | $7.72 Million | ▼ -9.3 pp |
| 2013 | 55.6% | $14.68 Million | $26.39 Million | $11.71 Million | ▲ +10.1 pp |
| 2012 | 45.5% | $11.88 Million | $26.10 Million | $14.22 Million | ▼ -16.2 pp |
| 2011 | 61.7% | $20.04 Million | $32.49 Million | $12.44 Million | ▼ -15.1 pp |
| 2010 | 76.8% | $29.71 Million | $38.69 Million | $8.98 Million | ▲ +42.4 pp |
| 2009 | 34.4% | $5.58 Million | $16.21 Million | $10.63 Million | ▼ -5.9 pp |
| 2008 | 40.3% | $11.41 Million | $28.28 Million | $16.87 Million | ▼ -36.4 pp |
| 2007 | 76.7% | $45.28 Million | $59.05 Million | $13.77 Million | ▼ -2.5 pp |
| 2006 | 79.2% | $28.57 Million | $36.06 Million | $7.49 Million | ▲ +62.2 pp |
| 2005 | 17.1% | $1.97 Million | $11.56 Million | $9.59 Million | ▲ +110.5 pp |
| 2003 | -93.4% | $-670.00K | $717.00K | $1.39 Million | — |